Spectrum of Movement Disorders in Kazakhstan: Five Years of Insights from Kazakhstan’s First Movement Disorder Center
Objective: To describe the spectrum, demographics, and trends of movement disorders patients seen at the first movement disorder (MD) center in Kazakhstan over five years.To…Interim Analysis of the Feasibility of Mediterranean-Ketogenic Dietary Interventions in Parkinson’s Disease
Objective: To assess the feasibility of combining Mediterranean and ketogenic dietary principles in persons with Parkinson’s disease (PwP). Background: Dietary interventions have been proposed as…Functional Changes Occuring During 10-Week Parkinson’s Disease Group Fitness Classes and Subsequent 8-Week Break
Objective: To examine the effects of participation in a 10-week Community-Based Group Exercise Class, followed by an 8-week break on the functional abilities of individuals…Comparison Between the 2MWT and the 6MWT as Measures of Walking Capacity in Parkinson’s Disease
Objective: The objective of this study was to compare the two-minute walk test (2MWT) to the six-minute walk test (6MWT) as a measure of walking…What assistive devices do people with Parkinson’s disease find most useful?
Objective: To determine what everyday assistive devices were deemed most useful by people with Parkinson’s disease (PwP) and their caregivers. Background: Numerous helpful assistive devices…Experiences of a personalised intervention to support self-management in PwP – PD-Care: Live Well with Parkinson’s
Objective: 1) Evaluate acceptability and feasibility of the intervention2) Understand barriers and enablers to engagement and intervention improvement recommendations Background: We co-designed the ‘Live Well…Sleep disorders in Parkinson’s disease
Objective: to specify the clinical features of sleep disorders in patients with PD and their impact on quality of life indicators; assessment of the relationship…Assembling a Cohort of Hyposmic Participants for Therapeutic Studies Aimed at Parkinson’s Disease (PD) Prevention
Objective: The goal of this project was to amass a cohort of individuals with hyposmia to later invite them to participate in clinical trials for…The 201 Trial in Untreated Parkinson’s Disease
Objective: To evalute the safety, tolerability, clinical benefit and protein pathology status following risvodetinib (IkT-148009) treatment in participants with untreated Parkinson's disease. Background: RIsvodetinib is…Identifying Subjects with Dopamine Transporter Deficit in a Population-based Recruitment Strategy: Kassel Data of Healthy Brain Ageing
Objective: To identify subjects with dopamine transporter (DaT) deficit being at high risk for prodromal PD. Background: Neurodegeneration and dopaminergic deficit in PD occur before the development…
- « Previous Page
- 1
- …
- 88
- 89
- 90
- 91
- 92
- …
- 338
- Next Page »